US Map / Wyoming
State WY

Clinical Trials in Wyoming

Recruiting clinical trials with at least one study location in Wyoming. Data updated daily from ClinicalTrials.gov.

Total Trials
8
Recruiting Now
8
← Back to US Map
Top Conditions in Wyoming
Chronic Lymphocytic Leukemia (2)RISS Stage I Plasma Cell Myeloma (2)RISS Stage II Plasma Cell Myeloma (2)Advanced Lung Non-Squamous Non-Small Cell Carcinoma (1)Metastatic Lung Non-Squamous Non-Small Cell Carcinoma (1)Recurrent Lung Non-Squamous Non-Small Cell Carcinoma (1)Stage IIIB Lung Cancer AJCC v8 (1)Stage IV Lung Cancer AJCC v8 (1)Small Lymphocytic Lymphoma (1)Plasma Cell Myeloma (1)Acute Lymphoblastic Leukemia (1)Acute Myeloid Leukemia (1)

Frequently Asked Questions — Clinical Trials in Wyoming

How many clinical trials are currently recruiting in Wyoming?
ClinicalMetric currently tracks 8 actively recruiting clinical trials with at least one location in Wyoming. The total number of registered studies—including active but not currently enrolling trials—is 8. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Wyoming?
Wyoming hosts clinical trials across a broad range of medical conditions, including Chronic Lymphocytic Leukemia, RISS Stage I Plasma Cell Myeloma, RISS Stage II Plasma Cell Myeloma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Wyoming serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Wyoming?
To join a clinical trial in Wyoming, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Wyoming maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Wyoming

NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04269902 Phase 3
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia...
Condition
Chronic Lymphocytic Leukemia
Enrollment
247 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT06592924 Phase 3
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Ca...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
830 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT06470243 Phase 3
Recruiting
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemothe...
Condition
Castration-Resistant Prostate Carcinoma
Enrollment
528 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT06876714 Phase 3
Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People W...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
1,524 pts
Location
United States, Puerto Rico
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT02523014 Phase 2
Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating ...
Condition
Intracranial Meningioma
Enrollment
124 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology